Do ARKG and GNOM hold the same stocks?

By their latest filings, 41% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, ARKG or GNOM?

ARKG has 5% of its weight in S&P 500 names and GNOM has 21%, so ARKG differs more from the index.

Which is cheaper, ARKG or GNOM?

ARKG charges 0.75% a year and GNOM charges 0.50%, so GNOM is cheaper. Fees come from each fund's prospectus.

Data as of Nov 4, 2026.

Thematic ETFs

ARKG vs GNOM: Holdings Overlap & Returns

Share on X Download as PDF

Over the year to Nov 4, 2026, ARKG returned +68.4% to GNOM's +66.6%; 41% of their weight is in the same names.

askIQ about this page

askIQ about ARKG and GNOM

Net assets: $2.1bn on Nov 2, 2026 for ARK Genomic Revolution ETF, and $104m on Oct 12, 2026 for Global X Genomics & Biotechnology ETF.

ARKG on its own →GNOM on its own →

At a glance

4.6%

ARKG in the S&P 500

21.0%

GNOM in the S&P 500

+68.4%

ARKG total return, 1 year

+66.6%

GNOM total return, 1 year

ARKG · 1 year to Nov 4, 2026 95% of its weight is outside the S&P 500

5% of ARKG's weight is in S&P 500 companies and 95% is outside the index. Holdings as of Nov 2, 2026.

GNOM · 1 year to Nov 4, 2026 79% of its weight is outside the S&P 500

21% of GNOM's weight is in S&P 500 companies and 79% is outside the index. Holdings as of Aug 31, 2026.

Pair scorecard

GNOM costs 0.25 points a year less; their one-year returns differ by 1.8 points; ARKG is far larger, $2.1bn against $104m.

ARKG vs GNOM: Holdings Overlap & Returns
Measure	ARKG	GNOM
Return
Measure	ARKG	GNOM
Total return, 1 year	+68.4%	+66.6%
Drawdown
Measure	ARKG	GNOM
Below its all-time high	55.5%, high on Jan 20, 2021	36.2%, high on Feb 8, 2021
Benchmark
Measure	ARKG	GNOM
What it tracks	Genomics and gene editing	Genomics and gene editing
Cost and size
Measure	ARKG	GNOM
Expense ratio	0.75%	0.50%
Net assets, as of Oct 12, 2026	$2.1bn	$104m
Holdings
Measure	ARKG	GNOM
Holdings in common	41%
Top ten holdings, share of the fund	58%	49%

Method

Risk and return

Apr 18, 2019 to Oct 30, 2026 · 393 weekly returns

ARKG GNOM

Return

Total return edge ARKG +67.4% +25.4%

Annualized edge ARKG +7.1% +3.0%

Price return edge ARKG +60.0% +23.4%

Risk

Volatility edge GNOM 44.4% 32.9%

Max drawdown edge GNOM −82.9% −73.5%

Risk-adjusted

Sharpe edge ARKG 0.31 0.17

Sortino edge ARKG 0.47 0.25

Calmar edge ARKG 0.09 0.04

Reading

From Apr 2019 to Oct 2026, ARKG returned more: +67.4% to +25.4%. GNOM swung less: 32.9% to 44.4%. GNOM fell less at its worst: −73.5% to −82.9%.

Full scorecard

9 measures, with how each is measured Open ↓

Risk and return: ARKG vs GNOM: Holdings Overlap & Returns
Measure	ARKG	GNOM	Edge	How it is measured
Return
Total return	+67.4%	+25.4%	ARKG	Price change plus distributions, reinvested.
Annualized	+7.1%	+3.0%	ARKG	Total return as a yearly rate.
Price return	+60.0%	+23.4%	ARKG	Price change alone, distributions left out.
Risk
Volatility	44.4%	32.9%	GNOM	Spread of weekly returns, annualized. Lower is steadier.
Downside deviation	29.2%	22.3%	GNOM	Like volatility, counting only weeks below the Treasury bill rate.
Max drawdown	−82.9%	−73.5%	GNOM	Deepest fall from a high to the low after it.
Risk-adjusted
Sharpe	0.31	0.17	ARKG	Return above Treasury bills per unit of volatility.
Sortino	0.47	0.25	ARKG	Return above Treasury bills per unit of downside deviation.
Calmar	0.09	0.04	ARKG	Annualized return divided by the max drawdown.

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 393 weekly returns. Cash rate: the 13-week Treasury bill.

What they share

41%

By the books each fund has filed, ARKG and GNOM hold 41% of their money in the same securities at the same weight. Holdings dated Aug 31, 2026 and Nov 2, 2026.

50%

0 half 100%

half

41% in common

Positions both hold · largest shared weight first ARKG GNOM

TWIST BIOSCIENCE CORP 7.42% 6.34%

10X GENOMICS INC-CLASS A 7.52% 5.48%

GUARDANT HEALTH INC 5.13% 5.28%

NATERA INC 4.67% 4.61%

ILLUMINA INC 4.26% 4.87%

CRISPR THERAPEUTICS AG 5.48% 3.00%

VERACYTE INC 3.80% 2.61%

BEAM THERAPEUTICS INC 3.84% 2.12%

ELI LILLY & CO 4.59% 1.85%

CAREDX INC 4.50% 1.78%

GENEDX HOLDINGS CORP 1.70% 1.69%

INTELLIA THERAPEUTICS INC 1.89% 1.11%

Only in one fund ↓

Only in ARKG

TEMPUS AI INC-CL A 9.85%

ABSCI CORP 5.08%

SCHRODINGER INC 2.93%

RECURSION PHARMACEUTICALS-A 2.91%

NURIX THERAPEUTICS INC 2.88%

ADAPTIVE BIOTECHNOLOGIES 2.28%

COMPASS PATHWAYS PLC 2.05%

IONIS PHARMACEUTICALS INC 1.79%

Only in GNOM

MODERNA, INC. 7.50%

Genscript Biotech Corp 3.81%

VERTEX PHARMACEUTICALS INCORPORATED 3.70%

BIO-TECHNE CORPORATION 3.67%

BIOMARIN PHARMACEUTICAL INC. 3.58%

ARROWHEAD PHARMACEUTICALS, INC. 3.31%

Qiagen N.V. 3.22%

Praxis Precision Medicines, Inc. 3.09%

Check overlap with more funds →

Window by window

Window by window: ARKG vs GNOM: Holdings Overlap & Returns
	Total return
Window	ARKG	GNOM
3 months	+20.5%	+24.5%
6 months	+60.0%	+49.4%
1 year	+68.4%	+66.6%
3 years	+90.8%	+81.6%
Since launchNot the same days: ARKG Oct 2014 · GNOM Apr 2019	+164.2%	+16.0%

Open this comparison in the app →

Side by side

ARKG ARK Genomic Revolution ETF · Holds 35 stocks in genomics and gene editing, 5% of its weight in S&P 500 companies GNOM Global X Genomics & Biotechnology ETF · Holds 50 stocks in genomics and gene editing, 21% of its weight in S&P 500 companies

Issuer ARK Global X

Theme Genomics and gene editing Genomics and gene editing

In the S&P 500 4.6% 21.0%

Active share vs the S&P 500 98.5% 97.6%

In the Nasdaq-100 0.0% 5.3%

Holdings 35 50

Top ten, share of the fund 58.5% 48.8%

Expense ratio 0.75% 0.50%

Fee for the differing part 0.76% 0.51%

Total return, 1 year +68.4% +66.6%

vs its benchmark not measured not measured

Below its high −55.5% −36.2%

Net assets, ARKG as of Nov 2, 2026 and GNOM as of Oct 12, 2026 $2.1bn $104m

As of Nov 4, 2026. Source: ETFIQ.

41% of the two portfolios are the same securities at the same weight.

Client brief:

The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.

Your saved page · Privacy.

Alert

About each fund

ARKG

By weight, 5% of ARKG's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 58% of the fund across 35 positions, as published by its issuer for Nov 2, 2026. Over the year to Nov 4, 2026 the fund returned +68.4% with distributions reinvested. It sits 55.5% below its all-time high of Jan 20, 2021.

GNOM

By weight, 21% of GNOM's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 49% of the fund across 50 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +66.6% with distributions reinvested. It sits 36.2% below its all-time high of Feb 8, 2021.

Questions people ask

Do ARKG and GNOM hold the same stocks?: By their latest filings, 41% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, ARKG or GNOM?: ARKG has 5% of its weight in S&P 500 names and GNOM has 21%, so ARKG differs more from the index.
Which is cheaper, ARKG or GNOM?: ARKG charges 0.75% a year and GNOM charges 0.50%, so GNOM is cheaper. Fees come from each fund's prospectus.

Other comparisons

ARKG vs GNMX ARKG vs IDNA ARKG vs IFRA ARKG vs KWEB GNOM vs IDNA GNOM vs GNMX GNOM vs PBPH GNOM vs PBE

Where to next

All thematic ETFs ranked by the S&P 500 Difference Score →How the scores are computed →ARKG on its own →GNOM on its own →ARKG holdings →GNOM dividend history →GNOM holdings →Method →Standards and sources →

Sources and dates

ARKG filings on SEC EDGAR ↗

ARKG prospectus with the expense ratio (SEC) ↗

ARK page for ARKG ↗

GNOM filings on SEC EDGAR ↗

GNOM prospectus with the expense ratio (SEC) ↗

Global X page for GNOM ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Every number is an ETFIQ calculation with distributions reinvested.

Cite this pageCitation, APA and Markdown

ETFIQ, ARKG against GNOM, data as of Nov 4, 2026. https://etfiq.com/compare/themes/arkg-vs-gnom

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.